BTI
FOLD

Blue Trust Inc’s Amicus Therapeutics FOLD Stock Holding History

Blue Trust Inc’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,997
Closed -$29.7K – 2619
2024
Q3 		$29.7K Buy
2,997
+2,831
+1,705% +$30.8K ﹤0.01% 1787
2024
Q2 		$1.96K Buy
+166
New +$1.7K ﹤0.01% 2445
2024
Q1 		– Sell
-240
Closed -$3K – 2380
2023
Q4 		$3K Buy
+240
New +$2.73K ﹤0.01% 2008

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blue Trust Inc's FOLD Position: Q4 2024 in Review

Blue Trust Inc sold out of Amicus Therapeutics (FOLD) in Q4 2024, closing a stake of 2,997 shares — an estimated $29.7K sold.

Blue Trust Inc first reported a position in FOLD in Q4 2023 and held it in 3 quarters. The position peaked at $29.7K in Q3 2024. 290 funds tracked by Wall St. Rank hold FOLD as of Q4 2024.

  • Blue Trust Inc reported no remaining Amicus Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 2,997 Amicus Therapeutics shares in Q4 2024, an estimated $29.7K.
  • Blue Trust Inc first reported a position in Amicus Therapeutics in Q4 2023 and held it in 3 quarters.
  • Blue Trust Inc's Amicus Therapeutics position peaked at $29.7K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.